48,849
edits
(→Columnar cell change: split out) |
|||
(32 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
[[Image:Diagram showing the lobes and ducts of a breast CRUK 307.svg|thumb|250px|Diagram of the structure of breast. (CRUK/WC)]] | [[Image:Diagram showing the lobes and ducts of a breast CRUK 307.svg|thumb|250px|Diagram of the structure of breast. (CRUK/WC)]] | ||
The '''breast''' is an important organ | The '''breast''' is an important organ that [[pathologist]]s see quite often because it is often afflicted by [[breast cancer|cancer]]. Before women started [[smoking]] in large numbers, it was a leading cause of cancer death in women. | ||
Fortunately, breast cancer, | Fortunately, breast cancer, in this day, has a relatively good prognosis if it is detected early. | ||
=Clinical= | =Clinical= | ||
===Clinical Presentations of Breast Pathology=== | ===Clinical Presentations of Breast Pathology=== | ||
*'''Abnormal/suspicious screening mammogram''' | *'''Abnormal/suspicious screening mammogram''' | ||
**Suspicious microcalcifications and/or suspicious mass. | |||
**Most common history on the specimen requisition | **Most common history on the specimen requisition | ||
**May be accompanied by a BI-RADS score | **May be accompanied by a [[BI-RADS]] score. | ||
*Nipple discharge. | *Nipple discharge. | ||
*Pain. | *Pain. | ||
Line 23: | Line 24: | ||
===Breast radiology=== | ===Breast radiology=== | ||
{{Main|Breast imaging reporting and data system}} | |||
=Specimens= | =Specimens= | ||
Line 48: | Line 39: | ||
#Mass lesion - usu. obvious what is going on; typically 3 levels. | #Mass lesion - usu. obvious what is going on; typically 3 levels. | ||
#Calcifications - abnormality may be very small; typically 10 levels. | #Calcifications - abnormality may be very small; typically 10 levels. | ||
Note - if you have a high BI-RADS score on the biopsy requisition, and no correlating histologic findings, be sure to correlate with the specimen radiograph, consider leveling the specimen to exhaustion and/or note the lack of a correlating lesion on your report. | |||
===Lumpectomy=== | ===Lumpectomy=== | ||
Line 65: | Line 58: | ||
***The myoepithelial layer is hard to see at times. | ***The myoepithelial layer is hard to see at times. | ||
***IHC can aid in visualizing the myoepithelial layer. | ***IHC can aid in visualizing the myoepithelial layer. | ||
***The immunostains used in breast pathology for the myoepithelial layer include: CK5/6, SMA, p63 | ***The immunostains used in breast pathology for the myoepithelial layer include: [[CK5/6]], SMA, [[p63]] and calponin. | ||
===Questions to Ask=== | ===Questions to Ask=== | ||
Line 82: | Line 75: | ||
**Do you know the morphologic criteria for in situ carcinoma? | **Do you know the morphologic criteria for in situ carcinoma? | ||
**Do you know how to use ICH to confirm an in situ carcinoma? | **Do you know how to use ICH to confirm an in situ carcinoma? | ||
**Do you know how to report an in situ carcinoma? | **Do you know how to report an in situ breast carcinoma? | ||
*Is it invasive carcinoma? | *Is it invasive carcinoma? | ||
Line 92: | Line 85: | ||
**Do you know how to use IHC for prognostication? | **Do you know how to use IHC for prognostication? | ||
**Do you understand the implications of triple negativity? | **Do you understand the implications of triple negativity? | ||
**Do you know how to report | **Do you know how to report an invasive breast carcinoma? | ||
*Is it something stromal/spindled? | *Is it something stromal/spindled? | ||
Line 99: | Line 92: | ||
====Papillary Lesions==== | ====Papillary Lesions==== | ||
*Nipple adenoma | *Nipple adenoma. | ||
*Intraductal papilloma | *Intraductal papilloma. | ||
*Papillary ductal carcinoma in situ | *Papillary ductal carcinoma in situ. | ||
*Intracystic papillary carcinoma | *Intracystic papillary carcinoma. | ||
*Intracystic papillary carcinoma with an invasive component | *Intracystic papillary carcinoma with an invasive component. | ||
*Invasive papillary carcinoma | *Invasive papillary carcinoma. | ||
====Basaloid Lesions==== | ====Basaloid Lesions==== | ||
*Adenoid | *Adenoid cystic carcinoma of the breast. | ||
*Intracystic | *Intracystic papillary breast carcinoma, solid variant. | ||
*Invasive | *Invasive papillary breast carcinoma, solid variant. | ||
*Medullary | *Medullary breast carcinoma. | ||
*Medullary-like | *Medullary-like breast carcinoma. | ||
**Know when to start a discussion about BRCA mutations, triple negativity and the 'basal-like molecular phenotype'. | **Know when to start a discussion about BRCA mutations, triple negativity and the 'basal-like molecular phenotype'. | ||
====Spindle Cell Lesions==== | ====Spindle Cell Lesions==== | ||
*Metaplastic | *Metaplastic breast carcinoma. | ||
*Treated | *Treated breast carcinoma. | ||
*Mammary | *Mammary myofibroblastoma. | ||
*Phyllodes | *Phyllodes Tumour - stromal component. | ||
*Desmoid | *Desmoid fibromatosis. | ||
*Nodular | *Nodular fasciitis. | ||
=== Additional resources === | === Additional resources === | ||
Line 129: | Line 122: | ||
*WebPathology - Breast [http://www.webpathology.com/atlas_map.asp?section=9] | *WebPathology - Breast [http://www.webpathology.com/atlas_map.asp?section=9] | ||
=Normal= | =Normal breast= | ||
==Resting== | ==Resting breast== | ||
*Glands -- normally has two cell layers (like the [[prostate]]). | *Glands -- normally has two cell layers (like the [[prostate]]). | ||
**Myoepithelial cells | **Myoepithelial cells | ||
Line 140: | Line 133: | ||
May be present: | May be present: | ||
*Calcification: | *[[Breast calcifications|Calcification]]: | ||
**Purple globs (with concentric rings) on H&E = calcium phosphate. | **Purple globs (with concentric rings) on H&E = calcium phosphate. | ||
***Q. How to remember? A. '''P'''urple = '''P'''hosphate. | ***Q. How to remember? A. '''P'''urple = '''P'''hosphate. | ||
**Calcium oxalate visible with (light) polarization - not | **Calcium oxalate visible with (light) [[polarization]] - not associated with [[breast cancer|malignancy]]. | ||
**Often in the lumen of a gland, may be in the stroma. | **Often in the lumen of a gland, may be in the stroma. | ||
**Calcific material typically has a well-demarcated border +/- "sharp corners". | **Calcific material typically has a well-demarcated border +/- "sharp corners". | ||
**Radiologists can pick-up calcs (calcifications) that are approximately 100 micrometers; if "calcs" is on the requisition one needs to find calcs this size.<ref>MUA. 1 October 2010.</ref> | **Radiologists can pick-up calcs (calcifications) that are approximately 100 micrometers; if "calcs" is on the requisition one needs to find calcs this size.<ref>MUA. 1 October 2010.</ref> | ||
***The large calcs seen on radiology are approximately 1/5 - 1/6 the size of a HPF, if the field of view (FOV) is ~0.55 mm (as is the case with 22 mm-10x eye pieces and a 40x objective). | ***The large calcs seen on radiology are approximately 1/5 - 1/6 the size of a HPF, if the field of view (FOV) is ~0.55 mm (as is the case with 22 mm-10x eye pieces and a 40x objective). | ||
Notes: | Notes: | ||
*The architecture is more important than the cytologic features in the diagnosis of malignancy in the breast;<ref>RS. 4 May 2010.</ref> low grade tumours have distorted architecture but normal/near normal cytology. | *The architecture is more important than the cytologic features in the diagnosis of malignancy in the breast;<ref>RS. 4 May 2010.</ref> low grade tumours have distorted architecture but normal/near normal cytology. | ||
===Image=== | |||
*[http://www.breastpathology.info/Images/calcs/FatNec1_700.jpg Breast with calcifications (breastpathology.info)]. | |||
*[http://www.wjso.com/content/7/1/70/figure/F3 Resting breast tissue (wjso.com)]. | |||
==Lactational changes== | ==Lactational changes== | ||
Line 177: | Line 171: | ||
*Luminal cells enlarged. | *Luminal cells enlarged. | ||
**Vacuolated cytoplasm. | **Vacuolated cytoplasm. | ||
**Hobnail morphology - hang into the lumen. | **[[Hobnail morphology]] - hang into the lumen. | ||
*Myoepithelial cells indistinct - after second trimester. | *Myoepithelial cells indistinct - after second trimester. | ||
*Lactational "adenoma" may undergo infarction - Imagine what an infarcted lactational adenoma could look like in a FNA specimen! | *Lactational "adenoma" may undergo infarction - Imagine what an infarcted lactational adenoma could look like in a FNA specimen! | ||
Line 262: | Line 256: | ||
{{familytree | D | | | | | | E | | | | | | F |D=Unremarkable<br>papillae|E=Atypia ''or'' arch. abnorm.<br>''or'' cellular proliferation|F=Neoplastic cells<br>present}} | {{familytree | D | | | | | | E | | | | | | F |D=Unremarkable<br>papillae|E=Atypia ''or'' arch. abnorm.<br>''or'' cellular proliferation|F=Neoplastic cells<br>present}} | ||
{{familytree | |!| | | |,|-|-|-|+|-|-|-|.| | | |!| |}} | {{familytree | |!| | | |,|-|-|-|+|-|-|-|.| | | |!| |}} | ||
{{familytree | G | | H | | I | | J | | K |G=[[intraductal papilloma|Benign<br>intraductal<br>papilloma]]|H=High grade atypia|I=Low grade atypia<br>''or'' abnorm. arch.|J=''Only'' cellular<br>proliferation|K=[[ | {{familytree | G | | H | | I | | J | | K |G=[[intraductal papilloma of the breast|Benign<br>intraductal<br>papilloma]]|H=High grade atypia|I=Low grade atypia<br>''or'' abnorm. arch.|J=''Only'' cellular<br>proliferation|K=[[Encapsulated papillary carcinoma of the breast|Intracystic<br> (encapsulated)<br>papillary ca.]]}} | ||
{{familytree | | | | | |!| | | |!| | | |!| | | | | |}} | {{familytree | | | | | |!| | | |!| | | |!| | | | | |}} | ||
{{familytree | | | | | L | | |!| | | N | | | | |L=[[DCIS]] in<br>papilloma|N=[[FEHUT]] in<br>papilloma}} | {{familytree | | | | | L | | |!| | | N | | | | |L=[[DCIS]] in<br>papilloma|N=[[FEHUT]] in<br>papilloma}} | ||
Line 294: | Line 288: | ||
===General=== | ===General=== | ||
*No increased risk of malignancy. | *No increased risk of malignancy. | ||
**Often ''not'' reported - as it has | **Often ''not'' reported - as it has no clinical signficance. | ||
*Has to be separated from ''[[moderate epithelial hyperplasia]]'' / ''[[florid epithelial hyperplasia]]''. | *Has to be separated from ''[[moderate epithelial hyperplasia]]'' / ''[[florid epithelial hyperplasia]]''. | ||
Line 311: | Line 305: | ||
==Apocrine metaplasia== | ==Apocrine metaplasia== | ||
{{Main|Apocrine metaplasia of the breast}} | |||
==Duct ectasia== | ==Duct ectasia== | ||
Line 353: | Line 323: | ||
==Fibrocystic change== | ==Fibrocystic change== | ||
{{Main|Breast fibrocystic changes}} | |||
*[[AKA]] ''fibrocystic changes'' | *[[AKA]] ''fibrocystic changes'' (abbreviated ''FCC''). | ||
==Columnar cell change== | ==Columnar cell change== | ||
{{Main|Columnar cell change of the breast}} | |||
==Gynecomastoid hyperplasia== | ==Gynecomastoid hyperplasia== | ||
*[[AKA]] ''gynecomastia''. | *[[AKA]] ''gynecomastia''. | ||
{{Main|Gynecomastoid hyperplasia}} | {{Main|Gynecomastoid hyperplasia}} | ||
==Breast prostheses== | |||
{{Main|Breast prostheses}} | |||
=Lesions with increased risk of malignancy= | =Lesions with increased risk of malignancy= | ||
==Florid epithelial hyperplasia== | ==Florid epithelial hyperplasia== | ||
*AKA ''florid epithelial hyperplasia of the usual type'', abbreviated ''FEHUT''. | *AKA ''florid epithelial hyperplasia of the usual type'', abbreviated ''FEHUT''. | ||
*AKA ''epithelial hyperplasia'' - term should be avoid as it could lead to confusion with ''[[mild epithelial hyperplasia]]''. | *AKA ''epithelial hyperplasia'' - term should be avoid as it could lead to confusion with ''[[mild epithelial hyperplasia]]''. | ||
*AKA ''usual ductal hyperplasia'', abbreviated ''UDH''. | |||
{{Main|Florid epithelial hyperplasia}} | |||
* | |||
==Sclerosing adenosis== | ==Sclerosing adenosis== | ||
{{Main|Sclerosing adenosis of the breast}} | |||
==Flat epithelial atypia== | ==Flat epithelial atypia== | ||
*Abbreviated ''FEA''. | |||
{{Main|Flat epithelial atypia}} | |||
* | |||
==Complex sclerosing lesion== | ==Complex sclerosing lesion== | ||
*[[AKA]] ''radial scar''. | *[[AKA]] ''radial scar''. | ||
{{Main|Complex sclerosing lesion}} | |||
=Stromal lesions= | =Stromal lesions= | ||
Line 564: | Line 392: | ||
==Intraductal papilloma== | ==Intraductal papilloma== | ||
*[[AKA]] ''papilloma''. | *[[AKA]] ''papilloma''. | ||
{{Main|Intraductal papilloma}} | {{Main|Intraductal papilloma of the breast}} | ||
==Lymphocytic mastitis== | ==Lymphocytic mastitis== |
edits